Regadenoson R-T Perfusion Imaging Trial
| Status: | Archived |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology, Women's Studies |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Reproductive |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2009 |
| End Date: | December 2010 |
Regadenoson Real Time Perfusion Imaging Trial
To exam the feasibility and accuracy of RTPE during vasodilator stress with 400micrograms of
the A2A Receptor agonist Regadenoson for detection of significant coronary artery disease
(CAD) in patients scheduled to undergo coronary angiography. Sensitivity, specificity , and
accuracy of perfusion and wall motion analysis to identify a coronary stenosis> 50% in
diameter by quantitive angiography will be analyzed
We found this trial at
2
sites
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
Click here to add this to my saved trials